• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract Assessing early tumour response and immune-related adverse events when undergoing combination nivolumab and ipilimumab therapy for advanced melanoma

byKathleen Lau
November 18, 2021
in StudyGraphics
0
Share on FacebookShare on Twitter

RELATED REPORTS

Rapid CT contrast washout differentiates adrenal adenomas from nonadenomas [Classics Series]

Breast ultrasound sensitive for cancer and carries a low false positive rate [Classics Series]

Abrocitinib is more effective than dupilumab for treatment of moderate-to-severe atopic dermatitis

Tags: #combination therapyadverse eventscancercase seriescomplete responsedermdermatologyimmune-related adverse eventsinduction therapyipilimumabmelanomaNivolumaboncologyprogressive diseaseretrospective studyserious adverse eventsskinskin cancertumor responsetumour response
Previous Post

Wellness Check: Exercise

Next Post

Selective serotonin reuptake inhibitor use may be associated with reduced mortality from COVID-19 infection

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Rapid CT contrast washout differentiates adrenal adenomas from nonadenomas [Classics Series]

August 5, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Breast ultrasound sensitive for cancer and carries a low false positive rate [Classics Series]

August 3, 2022
Topical pimecrolimus use for atopic dermatitis not linked to malignancy
Chronic Disease

Abrocitinib is more effective than dupilumab for treatment of moderate-to-severe atopic dermatitis

August 2, 2022
#VisualAbstract: Combination of spartalizumab plus dabrafenib and trametinib does not significantly improve survival in BRAFV600-mutated metastatic melanoma
StudyGraphics

#VisualAbstract: Combination of spartalizumab plus dabrafenib and trametinib does not significantly improve survival in BRAFV600-mutated metastatic melanoma

July 27, 2022
Next Post
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Selective serotonin reuptake inhibitor use may be associated with reduced mortality from COVID-19 infection

Few older adolescents meet recommended levels of physical activity

Exercise and dance may reduce cravings associated with methamphetamine abuse in women

#VisualAbstract In a Netherlands cohort, early mortality decreased in patients with multiple myeloma from 1999 onwards

#VisualAbstract In a Netherlands cohort, early mortality decreased in patients with multiple myeloma from 1999 onwards

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin D deficiency may be associated with sleep disorders in children
  • Prasinezumab therapy does not affect Parkinson’s Disease progression
  • Prior syncope presentation not associated with increased risk of motor vehicle collision
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.